Plasma cell myeloma (Q39157): Difference between revisions

← Older edit

@@ Property / Canonical URI @@
+https://id.who.int/icd/entity/526287100
@@ Property / Canonical URI: https://id.who.int/icd/entity/526287100 / rank @@
+Normal rank
@@ Property / CURIE @@
+CID11:2A83.1
@@ Property / CURIE: CID11:2A83.1 / rank @@
+Normal rank
@@ Property / Canary Token @@
+dki-india-2A83.1
@@ Property / Canary Token: dki-india-2A83.1 / rank @@
+Normal rank
@@ Property / Verification Status @@
+Concluído
@@ Property / Verification Status: Concluído / rank @@
+Normal rank
@@ Property / Knowledge Architect @@
+https://pauloleads.com.br/cases-publicos/
+Normal rank
@@ Property / Collection date @@
+August 2026Timestamp +2026-08-13T00:00:00Z
Timezone +00:00
Calendar Gregorian
Precision 1 day
Before 0
After 0
-Timestamp
++2026-08-13T00:00:00Z
-Timezone
++00:00
-Calendar
+Gregorian
-Precision
+day
 Before
 After
@@ Property / Collection date: 13 August 2026 / rank @@
+Normal rank
@@ Property / Linked ICD 10 @@
+C90.0
@@ Property / Linked ICD 10: C90.0 / rank @@
+Normal rank

Latest revision as of 04:28, 13 August 2026

A bone marrow-based plasma cell neoplasm usually characterised by presence of a serum monoclonal protein and/or urinary light chains. ”CRAB” criteria (calcium elevation (hypercalcaemia), renal failure, anaemia and bone lesions) separate symptomatic plasma cell myeloma from asymptomatic (smoldering) myeloma.

Language	Label	Description	Also known as
default for all languages	2A83.1
English	Plasma cell myeloma	A bone marrow-based plasma cell neoplasm usually characterised by presence of a serum monoclonal protein and/or urinary light chains. ”CRAB” criteria (calcium elevation (hypercalcaemia), renal failure, anaemia and bone lesions) separate symptomatic plasma cell myeloma from asymptomatic (smoldering) myeloma.